CRMD vs. ERO
CRMD (CorMedix Inc.) and ERO (Ero Copper Corp) are both stocks. CRMD operates in Biotechnology (Healthcare), while ERO operates in Copper (Basic Materials). Over the past 5 years, CRMD returned 1.21%/yr vs 4.57%/yr for ERO. At a 0.17 correlation, their price movements are largely independent.
Performance
CRMD vs. ERO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -24.85% return, which is significantly lower than ERO's 3.89% return.
CRMD
- 1D
- -2.46%
- 1M
- 16.53%
- YTD
- -24.85%
- 6M
- -23.93%
- 1Y
- -41.18%
- 3Y*
- 15.11%
- 5Y*
- 1.21%
- 10Y*
- -1.91%
ERO
- 1D
- 6.10%
- 1M
- -5.13%
- YTD
- 3.89%
- 6M
- 16.30%
- 1Y
- 87.56%
- 3Y*
- 14.46%
- 5Y*
- 4.57%
- 10Y*
- —
CRMD vs. ERO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -24.85% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -17.90% |
ERO Ero Copper Corp | 3.89% | 109.87% | -14.63% | 14.84% | -10.07% | -5.73% | -10.97% | 151.68% | 21.41% | 52.76% |
Correlation
The correlation between CRMD and ERO is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Oct 23, 2017 | 0.17 |
Fundamentals
CRMD:
$812.69M
ERO:
$3.09B
CRMD:
$2.10
ERO:
$2.80
CRMD:
4.16
ERO:
10.51
CRMD:
1.88
ERO:
3.32
CRMD:
1.86
ERO:
2.80
CRMD:
$400.05M
ERO:
$925.20M
CRMD:
$343.39M
ERO:
$394.67M
CRMD:
$207.97M
ERO:
$528.87M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. ERO — Risk / Return Rank
CRMD
ERO
CRMD vs. ERO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Ero Copper Corp (ERO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | ERO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.12 | ||
| Sortino ratioReturn per unit of downside risk | -2.52 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.26 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | 2.32 | -2.98 |
| Martin ratioReturn relative to average drawdown | -0.97 | 4.95 | -5.92 |
Loading charts...
Drawdowns
CRMD vs. ERO - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than ERO's maximum drawdown of -67.17%. Use the drawdown chart below to compare losses from any high point for CRMD and ERO.
Loading charts...
Drawdown Indicators
| CRMD | ERO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -67.17% | -31.11% |
Max Drawdown (1Y)Largest decline over 1 year | -62.26% | -37.97% | -24.29% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -59.84% | -2.42% |
Max Drawdown (5Y)Largest decline over 5 years | -66.91% | -63.89% | -3.02% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | — | — |
Current DrawdownCurrent decline from peak | -82.29% | -22.72% | -59.57% |
Average DrawdownAverage peak-to-trough decline | -77.55% | -27.04% | -50.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.56% | 17.75% | +24.81% |
Volatility
CRMD vs. ERO - Volatility Comparison
The current volatility for CorMedix Inc. (CRMD) is 12.12%, while Ero Copper Corp (ERO) has a volatility of 26.23%. This indicates that CRMD experiences smaller price fluctuations and is considered to be less risky than ERO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | ERO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.12% | 26.23% | -14.11% |
Volatility (6M)Calculated over the trailing 6-month period | 51.58% | 47.36% | +4.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.31% | 58.06% | +10.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.11% | 55.03% | +22.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.70% | 59.38% | +32.32% |
Dividends
CRMD vs. ERO - Dividend Comparison
Neither CRMD nor ERO has paid dividends to shareholders.
Financials
CRMD vs. ERO - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Ero Copper Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. ERO - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
ERO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported a gross profit of 103.33M and revenue of 259.52M. Therefore, the gross margin over that period was 39.8%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
ERO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported an operating income of 90.17M and revenue of 259.52M, resulting in an operating margin of 34.7%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
ERO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ero Copper Corp reported a net income of 107.26M and revenue of 259.52M, resulting in a net margin of 41.3%.
Frequently Asked Questions
CRMD and ERO have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ERO has higher volatility (26.23%) compared to CRMD (12.12%). In terms of maximum drawdown, CRMD dropped -98.28% vs ERO's -67.17%.
ERO currently has the higher Sharpe Ratio (1.52 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and ERO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer